Home > Resources > Whitepapers > Recruitment, Retention & Diversity: The Evolution of Patient Engagement in Clinical Trials

Cell and Gene Therapy, Industrial Impact

Recruitment, Retention & Diversity: The Evolution of Patient Engagement in Clinical Trials

January 23, 2023

Recruitment, Retention & Diversity

Recruitment, retention, and diversity are critical elements of clinical trials that, if insufficient, can jeopardize successful trial completion.

Spotlight

Nanotech Innovations, LLC

Located in Oberlin, Ohio, Nanotech Innovations (NTI) is at the forefront of nanotechnology research in Northern Ohio. The injection CVD system at the core of our product line was originally investigated at NASA Glenn Research Center. We recognize the demand for a reliable and affordable source of high purity carbon nanotubes. Our single-step process and instrumentation deliver nanotubes with low residual catalyst and virtually no amorphous carbon impurities. The Nanotech Innovations SSP-354 is a benchtop system that provides convenient access to exciting nanomaterials for education, research and product development.

OTHER WHITEPAPERS

Viral Vectors as a Gene Delivery Vehicle

whitePaper | August 5, 2022

The field of gene and cell therapy is experiencing a renaissance, with innovations in the use of viral vectors as a gene delivery vehicle being a key factor in the field’s growth.

Read More

A REVIEW OF THE RESEARCH TRENDS AND DEVELOPMENTS

whitePaper | May 9, 2022

In the last decade, there has been an encouraging shift in research, clinical development, and commercial activity to exploit the many biological roles of ribonucleic acid (RNA) for use in medicine.

Read More

2022 Global Life Sciences Outlook

whitePaper | January 7, 2022

While valuations for the life sciences sector in this past year have been mixed, the underlying performance and outlook for the sector is healthy

Read More

Synthetic Biology Biotechnology and AgTech

whitePaper | March 12, 2022

CRISPR, gene editing, biotech, precision agriculture and automation influencing the future of business, government, food, medicine, geopolitics and society

Read More

Further Discussion on Plasmids to Establish Release Specifications Using a Risk-Based Approach to Manage Supply

whitePaper | December 6, 2022

BioPhorum’s mission is to create environments where the global biopharmaceutical industry can collaborate and accelerate its rate of progress, for the benefit of all.

Read More

Accelerating the Biomanufacturing Revolution

whitePaper | February 11, 2022

The biomanufacturing revolution is here. Recent advancements in the field of synthetic biology have enabled significant cost reductions in foundational bioengineering unit operations such as DNA synthesis and sequencing.

Read More

Viral Vectors as a Gene Delivery Vehicle

whitePaper | August 5, 2022

The field of gene and cell therapy is experiencing a renaissance, with innovations in the use of viral vectors as a gene delivery vehicle being a key factor in the field’s growth.

Read More

A REVIEW OF THE RESEARCH TRENDS AND DEVELOPMENTS

whitePaper | May 9, 2022

In the last decade, there has been an encouraging shift in research, clinical development, and commercial activity to exploit the many biological roles of ribonucleic acid (RNA) for use in medicine.

Read More

2022 Global Life Sciences Outlook

whitePaper | January 7, 2022

While valuations for the life sciences sector in this past year have been mixed, the underlying performance and outlook for the sector is healthy

Read More

Synthetic Biology Biotechnology and AgTech

whitePaper | March 12, 2022

CRISPR, gene editing, biotech, precision agriculture and automation influencing the future of business, government, food, medicine, geopolitics and society

Read More

Further Discussion on Plasmids to Establish Release Specifications Using a Risk-Based Approach to Manage Supply

whitePaper | December 6, 2022

BioPhorum’s mission is to create environments where the global biopharmaceutical industry can collaborate and accelerate its rate of progress, for the benefit of all.

Read More

Accelerating the Biomanufacturing Revolution

whitePaper | February 11, 2022

The biomanufacturing revolution is here. Recent
advancements in the field of synthetic biology
have enabled significant cost reductions in
foundational bioengineering unit operations such
as DNA synthesis and sequencing.

Read More

More Whitepapers

Spotlight

Nanotech Innovations, LLC

Located in Oberlin, Ohio, Nanotech Innovations (NTI) is at the forefront of nanotechnology research in Northern Ohio. The injection CVD system at the core of our product line was originally investigated at NASA Glenn Research Center. We recognize the demand for a reliable and affordable source of high purity carbon nanotubes. Our single-step process and instrumentation deliver nanotubes with low residual catalyst and virtually no amorphous carbon impurities. The Nanotech Innovations SSP-354 is a benchtop system that provides convenient access to exciting nanomaterials for education, research and product development.

Events